Advocacy 18 September 2023 Fiasp insulin to remain on the Pharmaceutical Benefits Scheme Continue Reading
Advocacy 23 June 2023 Diabetes Alliance submission to the Health Technology Assessments Policy and Methods Review Continue Reading
Advocacy 12 May 2023 The 2023-24 Budget delivers ‘good news for many people living with diabetes’ Continue Reading
Advocacy 17 March 2023 Health Minister Butler’s intervention on Fiasp welcomed by Diabetes Australia Continue Reading
Advocacy 3 June 2022 Diabetes Australia stands up for people with type 2 as Ozempic shortage hits Australia Continue Reading
